Saturday 17 October 2026
Export AVTR’s income statement to Excel — free account
Avantor, Inc.
AVTR Healthcare Medical Instruments & Supplies
Avantor, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.6 billion, down 3.41% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 33.3%, free cash flow grew 12.7% and total debt fell 12.8%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
16.42
0.33
+2.05%
Follow AVTR
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 4 | 4 |
+8 more TTM periods Free account |
| (9.70%) | (9.44%) | (9.20%) | (1.48%) | ||
| (4.74%) | (4.60%) | (4.44%) | (0.67%) | ||
ROIC |
(2.09%) | (2.01%) | (1.68%) | 1.81% | |
Return on Tangible Assets |
(31.20%) | (30.58%) | (28.83%) | (5.47%) | |
Average Days of Receivables |
63.36 | 61.54 | 59.86 | 59.82 | |
Free Cash Flow per Share |
0.67 | 0.65 | 0.73 | 0.77 | |
Free Cash Flow |
454.70 | 438.90 | 495.00 | 523.60 | |
Capital Expenditures |
(142.30) | (134.30) | (128.80) | (120.80) | |
| Other line items | |||||
Cash ROIC |
4.72% | 4.53% | 5.01% | 5.41% | |
Accounts Receivable Turnover |
5.73 | 5.95 | 6.21 | 6.07 | |
Accounts Payable Turnover |
6.16 | 6.28 | 6.28 | 6.44 | |
Inventory Turnover |
5.56 | 5.70 | 5.70 | 5.58 | |
Average Days of Payables |
60.65 | 60.37 | 61.35 | 57.41 | |
Days of Inventory on Hand |
67.62 | 66.51 | 67.68 | 66.04 | |
Tax Rate |
0.22 | 0.17 | 0.20 | (2.32) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.37% | 24.56% | 24.35% | 23.95% | |
Share Based Compensation of Revenue |
0.65% | 0.65% | 0.71% | 0.70% | |
Interest Coverage |
(1.81) | (1.72) | (1.45) | 1.52 | |
Operating CF/Net income |
(1.03) | (1.04) | (1.18) | (7.84) | |
Depreciation/Fixed assets |
0.55 | 0.55 | 0.55 | 0.55 | |
Capex/Depreciation |
(0.33) | (0.32) | (0.31) | (0.29) | |
Revenue per Share |
9.70 | 9.70 | 9.63 | 9.65 | |
Operating CF per Share |
0.88 | 0.85 | 0.92 | 0.95 | |
Capex per Share |
(0.21) | (0.20) | (0.19) | (0.18) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 |
Columns are period end dates